Literature DB >> 22054029

Consumers young and old: segmenting the target markets for direct-to-consumer prescription drug advertising.

Jennifer Gerard Ball1, Danae Manika, Patricia Stout.   

Abstract

Direct-to-consumer pharmaceutical advertising (DTCA) studies have typically focused on older adults or a general population of adults. However, college students are viable targets for DTCA and are receiving more research attention in this area. In this article, we compare college students with two adult age segments. Our findings indicate all age groups had relatively high awareness of DTCA and similar attitudes and behavioral responses to the ads. However, there were significant differences in media use and health characteristics as well as the factors predicting DTCA ad trust, attitudes, and behavioral intentions. Implications and future research suggestions are discussed.

Mesh:

Substances:

Year:  2011        PMID: 22054029     DOI: 10.1080/07359683.2011.623112

Source DB:  PubMed          Journal:  Health Mark Q        ISSN: 0735-9683


  4 in total

Review 1.  Effects of Direct-To-Consumer Advertising on Patient Prescription Requests and Physician Prescribing: A Systematic Review of Psychiatry-Relevant Studies.

Authors:  Sara J Becker; Miriam M Midoun
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

2.  A Study of the Frequency and Social Determinants of Exposure to Cancer-Related Direct-to-Consumer Advertising Among Breast, Prostate, and Colorectal Cancer Patients.

Authors:  Andy S L Tan
Journal:  Health Commun       Date:  2014-10-30

3.  An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs.

Authors:  Janelle Applequist; Jennifer Gerard Ball
Journal:  Ann Fam Med       Date:  2018-05       Impact factor: 5.166

Review 4.  Media, messages, and medication: strategies to reconcile what patients hear, what they want, and what they need from medications.

Authors:  Richard L Kravitz; Robert A Bell
Journal:  BMC Med Inform Decis Mak       Date:  2013-12-06       Impact factor: 2.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.